Clinical Trials on Platinum Sensitive Ovarian Cancer in Italy
Total 207 results
-
National Cancer Institute, NaplesRecruitingBRCA Wild Type Platinum Sensitive Recurrent Ovarian CancerItaly
-
AstraZenecaISTITUTO REGINA ELENA - CENTRO RICERCHE SPERIMENTALITerminatedPatients With Advanced Ovarian Cancer Sensitive to Platinum-based ChemotherapyItaly, Germany
-
AstraZenecaMerck Sharp & Dohme LLC; European Network of Gynaecological Oncological Trial... and other collaboratorsActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum Sensitive | BRCA MutatedKorea, Republic of, France, China, Italy, United States, Israel, United Kingdom, Canada, Japan, Germany, Brazil, Netherlands, Belgium, Poland, Australia, Russian Federation, Spain
-
Eisai Inc.CompletedPlatinum-Sensitive Ovarian Cancer in First RelapseUnited States, Italy, United Kingdom, Germany, Spain, Belgium, Japan
-
AstraZenecaRTI Health Solutions; A+A Healthcare Marketing Research; Freelance CRA (FCRA)CompletedPlatinum-sensitive Recurrent Serous Ovarian CancerFrance, Italy, Korea, Republic of, Spain, United Kingdom, Germany, Belgium, Israel, Portugal, Netherlands, Switzerland, Canada, Australia
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT); US Oncology... and other collaboratorsCompletedA Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerOvarian Neoplasms | Platinum Sensitive Ovarian CancerUnited States, Belgium, Sweden, Germany, Israel, Austria, Canada, Denmark, Spain, Italy, United Kingdom, Poland, France, Hungary, Norway
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...RecruitingRecurrent, Platinum-resistant Ovarian CancerItaly
-
Catholic University of the Sacred HeartCompletedOvarian Epithelial Cancer Recurrent | Platinum-resistantItaly
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...European Institute of Oncology; ASST Santi Paolo e CarloRecruitingMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)Italy
-
Azienda Ospedaliero-Universitaria CareggiNot yet recruitingOligometastatic Hormone Sensitive Prostate CancerItaly
-
Mersana TherapeuticsIQVIA Biotech; PSI CRORecruitingPlatinum Resistant Ovarian Cancer | Non Small Cell Lung Cancer MetastaticUnited States, Spain, United Kingdom, Australia, France, Austria, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, Hungary, Italy, Lithuania, New Zealand, Norway, Poland, Sweden
-
Istituto Oncologico Veneto IRCCSAssociation for Translational Research in Oncology (AS.T.R.O.)CompletedEndocrine Sensitive HER2+/HR+ Breast CancerItaly
-
National Cancer Institute, NaplesMario Negri Institute for Pharmacological ResearchActive, not recruitingRecurrent Ovarian CancerFrance, Italy, Switzerland, Monaco, Greece
-
Catholic University of the Sacred HeartCompletedStage IIIC Ovarian CancerItaly
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Italy, Spain, Belgium, Poland, Canada, Korea, Republic of, Brazil, Czechia, Hungary, Israel, Argentina, Mexico
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingEpithelial Ovarian Cancer | OrganoidsItaly
-
Fondazione Policlinico Universitario Agostino Gemelli...Unknown
-
Mural Oncology, IncMerck Sharp & Dohme LLCRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Taiwan, Canada, Israel, France, United Kingdom, Germany, Belgium, Czechia, Singapore, Australia, Austria, Italy
-
Catholic University of the Sacred HeartUnknownAdvanced Ovarian Cancer (Stage III or IV) After Neoadjuvant ChemotherapyItaly
-
University of UdineRecruitingOvarian Cancer Stage IV | Ovarian Cancer Stage IIIItaly
-
National Cancer Institute, NaplesRecruitingLow-grade Serous Ovarian Carcinoma | Recurrent Invasive Borderline Serous Ovarian CancerItaly
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruiting
-
AGO Study GroupCancer Research UK; ARCAGY/ GINECO GROUP; Grupo Español de Investigación en Cáncer... and other collaboratorsCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerSpain, France, Denmark, Belgium, Germany, Austria, China, Italy, Korea, Republic of, Norway, Sweden, United Kingdom
-
AGC Biologics S.p.A.CompletedOvarian Cancer Metastatic RecurrentItaly
-
Aravive, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...TerminatedPlatinum-resistant Ovarian CancerUnited States, Spain, Belgium, Canada, Georgia, Czechia, China, Poland, France, United Kingdom, Italy
-
MorphotekEisai Europe Ltd. (United Kingdom)TerminatedOvarian CancerUnited States, Hong Kong, Netherlands, Spain, Korea, Republic of, Belgium, Taiwan, Israel, Japan, France, United Kingdom, Singapore, Italy, Argentina, India, Germany, Hungary, Australia, Portugal, Russian Federation, Canada, Poland, Greec... and more
-
Mario Negri Institute for Pharmacological ResearchHoffmann-La Roche; PharmaMarCompletedOvarian Epithelial Cancer RecurrentItaly
-
Universitaire Ziekenhuizen KU LeuvenUZ Leuven, Leuven, Belgium; Policlinico Universitario A. Gemelli, IRCSS, Rome... and other collaboratorsRecruitingCervical Cancer | Ovarian Neoplasms | Ovarian Cancer | Metastatic Cancer | Pelvic Cancer | Endometrial Cancer | Ovarian Carcinoma | Uterus Cancer | Sarcoma UterusBelgium, Czechia, Italy, Sweden
-
Centro di Riferimento Oncologico - AvianoRecruitingEpithelial Ovarian CancerItaly
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedSentinel Lymph Node | Ovarian Cancer Stage IItaly
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaOspedale SS Giovanni e Paolo, VeneziaRecruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...GlaxoSmithKlineRecruiting
-
ImmunoGen, Inc.Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, France, Belgium, Spain, Ireland, Italy, Australia, Canada
-
Catholic University of the Sacred HeartUnknownFirst Recurrence of Ovarian CancerItaly
-
European Organisation for Research and Treatment...Terminated
-
Catholic University of the Sacred HeartUnknown
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
Azienda Ospedaliera San Giovanni BattistaHumanitas Hospital, ItalyUnknown
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain
-
National Cancer Institute, NaplesRecruiting
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Unknown
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingPatients With Suspected Ovarian Carcinoma | Non Oncological Patients or With EndometriosisItaly
-
Azienda Ospedaliera di PadovaUniversity of PadovaRecruiting
-
AGC Biologics S.p.A.Completed
-
Catholic University of the Sacred HeartUnknownBRCA1 and BRCA2 Mutation Carrier and BRCAness PhenotypeItaly
-
Catholic University of the Sacred HeartCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...Fondazione Umberto VeronesiNot yet recruitingGynecologic Cancer | Ovarian Cancer | Venous Thromboembolism | Cervix Cancer | Endometrial Cancer | Vaginal Cancer | Cancer-associated ThrombosisItaly
-
Catholic University of the Sacred HeartCompleted
-
National Cancer Institute, NaplesRecruiting